Microcapsule preparation and preparation thereof and microcapsule suspending agent
A technology of microcapsule suspension agent and microcapsule, which is applied in the directions of insecticides, acaricides, biocides, etc., can solve the problem of unsatisfactory synergistic effect, demulsification, release and persistence, particle size increase, etc. problem, to achieve the effect of improving bioavailability, consistent release and lasting effect, and small average particle size
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0034] Correspondingly, the embodiment of the present invention also provides a preparation method of the above microcapsule preparation. In one embodiment, the preparation method of the microcapsule preparation of the embodiment of the present invention comprises the following steps:
[0035] Step S01: after dissolving pyraclostrobin technical material, abamectin technical drug and lambda-cyhalothrin technical drug in an organic solvent, adding oil-soluble cyst wall material for mixing treatment, and preparing an oil phase;
[0036] Step S02: dissolving the emulsified dispersant in water to prepare an aqueous phase;
[0037] Step S03: mixing and shearing the water phase and the oil phase to form an O / W emulsion;
[0038] Step S04: adding a water-soluble capsule wall material to the O / W emulsion for interfacial polymerization.
[0039] Specifically, as an embodiment of the present invention, in the above step S01, the mass ratio of the percent active substances of pyraclostr...
Embodiment 1
[0055]This example provides a pyraclostrobin · abamectin · lambda-cyhalothrin microcapsule preparation and 20% microcapsule suspension and its preparation method.
[0056] The microcapsule preparation of this embodiment uses the microcapsule film layer formed by the polymerization reaction of 1,6-hexamethylene diisocyanate and ethylenediamine, and the molar ratio of the isocyanate group functional group of the oil-soluble capsule wall material to the amine group functional group of the water-soluble capsule wall material is 1:1, its encapsulation mass ratio is 2.5:2.5:15.0 pyraclostrobin · abamectin · lambda-cyhalothrin active ingredient.
Embodiment 20
[0057] The preparation method of the present embodiment 20% microcapsule suspension:
[0058] S11: 26.0g of pyraclostrobin (96.0%), 26.3g of avermectin (95.0%) and 154.6g of lambda-cyhalothrin (97.0%) were dissolved in 100.0g of solvent oil In the mixed solvent of S-150 and 10.0g of sec-butyl acetate, add 25.0g of 1,6-hexamethylene diisocyanate (HMDI) and stir evenly to prepare an oil phase;
[0059] S12: 20.0g lignosulfonate (Ultrazine NA) and 8.0g polyoxyethylene sorbitan fatty acid ester (Tween-80) were dissolved in 372g deionized water to prepare an aqueous phase;
[0060] S13: adding the oil phase to the water phase, shearing to an O / W emulsion with an average particle size of 0.5 μm to 12 μm;
[0061] S14: Slowly add 89.5 g of 10% ethylenediamine aqueous solution under stirring, keep the reaction at 30°C±5°C for 2.0h, and cool to room temperature;
[0062] S15: Add 50.0g ethylene glycol, add 20% polyvinyl alcohol ( 502) 50.0g, silicone defoamer 1.0g and sodium benzoa...
PUM
Property | Measurement | Unit |
---|---|---|
The average particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com